DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
Condition: Small Cell Lung Cancer Interventions: Drug: DS-3201b; Drug: irinotecan Sponsor: Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials